Cargando…

Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders

Increasing evidence strongly supports the key role of neuroinflammation in the pathophysiology of neurodegenerative diseases, such as Alzheimer’s disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Neuroinflammation may alter synaptic transmission contributing to the progression of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Assogna, Martina, Di Lorenzo, Francesco, Martorana, Alessandro, Koch, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405819/ https://www.ncbi.nlm.nih.gov/pubmed/36009055 http://dx.doi.org/10.3390/biom12081161

Ejemplares similares

Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans
por: Landolfo, Eugenia, et al.
Publicado: (2022)

Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABA(B)-ergic activity and cortical plasticity in long COVID-19 syndrome
por: Versace, Viviana, et al.
Publicado: (2023)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
por: Motta, Caterina, et al.
Publicado: (2023)

Delay of Morphine Tolerance by Palmitoylethanolamide
por: Di Cesare Mannelli, Lorenzo, et al.
Publicado: (2015)

The Basal Pharmacology of Palmitoylethanolamide
por: Rankin, Linda, et al.
Publicado: (2020)

Regional Precuneus Cortical Hyperexcitability in Alzheimer's Disease Patients
por: Casula, Elias P., et al.
Publicado: (2022)

Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals
por: Martorana, Alessandro, et al.
Publicado: (2014)

Palmitoylethanolamide for the treatment of pain: pharmacokinetics, safety and efficacy
por: Gabrielsson, Linda, et al.
Publicado: (2016)

Palmitoylethanolamide: A Natural Compound for Health Management
por: Clayton, Paul, et al.
Publicado: (2021)

Orofacial Pain Management: An Overview of the Potential Benefits of Palmitoylethanolamide and Other Natural Agents
por: Santonocito, Simona, et al.
Publicado: (2023)

ALIAmides Update: Palmitoylethanolamide and Its Formulations on Management of Peripheral Neuropathic Pain
por: D’Amico, Ramona, et al.
Publicado: (2020)

An Update of Palmitoylethanolamide and Luteolin Effects in Preclinical and Clinical Studies of Neuroinflammatory Events
por: Cordaro, Marika, et al.
Publicado: (2020)

Impaired anandamide/palmitoylethanolamide signaling in hippocampal glutamatergic neurons alters synaptic plasticity, learning, and emotional responses
por: Zimmermann, Tina, et al.
Publicado: (2018)

Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications
por: Valenza, Marta, et al.
Publicado: (2022)

Looking for Responders among Women with Chronic Pelvic Pain Treated with a Comicronized Formulation of Micronized Palmitoylethanolamide and Polydatin
por: Indraccolo, Ugo, et al.
Publicado: (2022)

Effect of ultramicronized-palmitoylethanolamide and co-micronized palmitoylethanolamide/polydatin on chronic pelvic pain and quality of life in endometriosis patients: An open-label pilot study
por: Stochino Loi, Emanuela, et al.
Publicado: (2019)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
por: Seol, Tai-Kyung, et al.
Publicado: (2017)

c-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases
por: Gutiérrez, Daniela A., et al.
Publicado: (2022)

Dysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases
por: Purro, Silvia A., et al.
Publicado: (2014)

Molecular underpinnings of neurodegenerative disorders: striatal-enriched protein tyrosine phosphatase signaling and synaptic plasticity
por: Lombroso, Paul J., et al.
Publicado: (2016)

Possible Anandamide and Palmitoylethanolamide involvement in human stroke
por: Naccarato, Marcello, et al.
Publicado: (2010)

Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
por: Colizzi, Marco, et al.
Publicado: (2021)

Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art
por: della Rocca, Giorgia, et al.
Publicado: (2022)

“Is dopamine involved in Alzheimer's disease?”
por: Martorana, Alessandro, et al.
Publicado: (2014)

Intestinal Disorder in Zebrafish Larvae (Danio rerio): The Protective Action of N-Palmitoylethanolamide-oxazoline
por: Di Paola, Davide, et al.
Publicado: (2022)

Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders
por: Mottahedin, Amin, et al.
Publicado: (2017)

Synaptic dysfunction and septin protein family members in neurodegenerative diseases
por: Marttinen, Mikael, et al.
Publicado: (2015)

Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers
por: Camporesi, Elena, et al.
Publicado: (2021)

Frontotemporal Dementia, Where Do We Stand? A Narrative Review
por: Antonioni, Annibale, et al.
Publicado: (2023)

Effects of the glial modulator palmitoylethanolamide on chronic pain intensity and brain function
por: Alshelh, Zeynab, et al.
Publicado: (2019)

Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
por: Noce, Annalisa, et al.
Publicado: (2021)

Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
por: della Rocca, Giorgia, et al.
Publicado: (2021)

Cerebellar theta burst stimulation modulates short latency afferent inhibition in Alzheimer's disease patients
por: Di Lorenzo, Francesco, et al.
Publicado: (2013)

Optical Coherence Tomography Angiography in Neurodegenerative Disorders †
por: Pellegrini, Marco, et al.
Publicado: (2020)

Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain
por: Impellizzeri, Daniela, et al.
Publicado: (2014)

Ultramicronized Palmitoylethanolamide in the Management of Sepsis-Induced Coagulopathy and Disseminated Intravascular Coagulation
por: D’Amico, Ramona, et al.
Publicado: (2021)

Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review
por: Passavanti, Maria Beatrice, et al.
Publicado: (2019)

Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV
por: Di Liberto, Giovanni, et al.
Publicado: (2022)

Identification of a Widespread Palmitoylethanolamide Contamination in Standard Laboratory Glassware
por: Angelini, Roberto, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_jdskoia09ah71ee82ca0ft34kv